Chang GC - Search Results

1

S-1 plus cisplatin as first-line treatment of patients with advanced non-small cell lung cancer in Taiwan.

Lai CL, Wei YF, Hsia TC, Chang GC, Wu JT, Chen JY, Chen YM. Lai CL, et al. Among authors: chang gc. Asia Pac J Clin Oncol. 2020 Apr;16(2):e68-e73. doi: 10.1111/ajco.13294. Epub 2019 Nov 26. Asia Pac J Clin Oncol. 2020. PMID: 31773897

2

Serial-measured versus estimated creatinine clearance in patients with non-small cell lung cancer receiving cisplatin-based chemotherapy.

Chang GC, Yang TY, Shih CM, Lin LY, Lee HS, Chiang CD. Chang GC, et al. J Formos Med Assoc. 2003 Apr;102(4):257-61. J Formos Med Assoc. 2003. PMID: 12833190

3

Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status.

Chang GC, Chen KC, Yang TY, Yin MC, Lin CP, Kuo BI, Hsu JY. Chang GC, et al. Invest New Drugs. 2005 Jan;23(1):73-7. doi: 10.1023/B:DRUG.0000047108.39129.7c. Invest New Drugs. 2005. PMID: 15528983

4

Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer.

Chang GC, Yang TY, Chen KC, Yin MC, Wang RC, Lin YC. Chang GC, et al. J Clin Oncol. 2004 Nov 15;22(22):4646-8. doi: 10.1200/JCO.2004.02.168. J Clin Oncol. 2004. PMID: 15542815 No abstract available.

5

Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines.

Chang JT, Chang GC, Ko JL, Liao HY, Liu HJ, Chen CC, Su JM, Lee H, Sheu GT. Chang JT, et al. Among authors: chang gc. Int J Cancer. 2006 Jan 15;118(2):317-25. doi: 10.1002/ijc.21372. Int J Cancer. 2006. PMID: 16080190

6

Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer.

Yang CH, Shih JY, Chen KC, Yu CJ, Yang TY, Lin CP, Su WP, Gow CH, Hsu C, Chang GC, Yang PC. Yang CH, et al. Among authors: chang gc. Cancer. 2006 Oct 15;107(8):1873-82. doi: 10.1002/cncr.22220. Cancer. 2006. PMID: 16989002 Free article.

7

Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in Taiwan.

Perng RP, Chen CY, Chang GC, Hsia TC, Hsu NY, Tsai YH, Tsai CM, Yang CH, Chen YM, Yu CJ, Lee JJ, Hsu HS, Yu CT, Kao EL, Chiu CH. Perng RP, et al. Among authors: chang gc. Jpn J Clin Oncol. 2007 Jan;37(1):9-15. doi: 10.1093/jjco/hyl119. Epub 2006 Dec 1. Jpn J Clin Oncol. 2007. PMID: 17142253

8

A five-gene signature and clinical outcome in non-small-cell lung cancer.

Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC. Chen HY, et al. Among authors: chang gc. N Engl J Med. 2007 Jan 4;356(1):11-20. doi: 10.1056/NEJMoa060096. N Engl J Med. 2007. PMID: 17202451 Free article.

9

Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.

Chang GC, Tsai CM, Chen KC, Yu CJ, Shih JY, Yang TY, Lin CP, Hsu JY, Chiu CH, Perng RP, Yang PC, Yang CH. Chang GC, et al. J Thorac Oncol. 2006 Jul;1(6):520-5. J Thorac Oncol. 2006. PMID: 17409911 Free article.

10

High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy.

Perng RP, Yang CH, Chen YM, Chang GC, Lin MC, Hsieh RK, Chu NM, Lai RS, Su WC, Tsao CJ, Hsia TC, Chen HC, Chen CH, Huang MS, Wang JL, Ho ML, Chung CY, Yu CJ, Chang WC, Kuo HP, Yu CT, Lin ZZ, Kao WY. Perng RP, et al. Among authors: chang gc, chang wc. Lung Cancer. 2008 Oct;62(1):78-84. doi: 10.1016/j.lungcan.2008.02.023. Epub 2008 Apr 18. Lung Cancer. 2008. PMID: 18423781 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters